COMMUNIQUÉS West-GlobeNewswire

GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025
06/02/2025
2 new ACLF clinical trials expected to initiate in 1Q25 3 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trial Data of on-going Phase 1b also expected by [...]
GENFIT présente le design de ses prochains essais cliniques et rappelle les grandes étapes de développement et données cliniques attendues en 2025
06/02/2025
Lancements de 2 nouveaux essais cliniques dans l’ACLF prévus au premier trimestre 2025 Résultats de 3 essais cliniques attendus dans l’ACLF d’ici fin 2025, dont ceux de l’essai de Phase 2 UNVEIL-IT® en cours Données de [...]
LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025
06/02/2025
SCOTTSDALE, Ariz., Feb. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its fourth quarter and full year 2024 [...]
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
06/02/2025
TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board
06/02/2025
REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of [...]
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/02/2025
SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]
Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
06/02/2025
CAMBRIDGE, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
06/02/2025
GERMANTOWN, Md., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose [...]
BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
06/02/2025
LOUISVILLE, Ky., Feb. 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its fourth quarter and full year 2024 [...]
MannKind to Present at Upcoming Investor Conferences
06/02/2025
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of innovative inhaled therapeutic products [...]
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
06/02/2025
Raised approximately $2.118 million in gross proceeds since the beginning of 2025 WASHINGTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical [...]
Lytus Technologies Expands HealthTech Initiatives and Strengthens Growth Trajectory
06/02/2025
Lytus Healthcare launched to transform patient care in India Company positioned to build on revenue growth momentum Secures strategic financing to fuel next-generation technology expansion Mumbai, India, Feb. 06, 2025 ( [...]
CARBIOS is pleased that the European Commission has authorised the ‘Circular Economy’ State aid scheme
06/02/2025
A significant step towards the payment to CARBIOS of grant subsidies validated by ADEME and the Grand Est Region, totalling €42.5m, for the construction of the CARBIOS Longlaville biorecycling plant in France CARBIOS [...]
CARBIOS se réjouit de l'autorisation du régime d'aide d'État "Économie circulaire" par la Commission européenne
06/02/2025
Une étape significative pour le versement des subventions validées par la Région Grand Est et l’ADEME, d’un montant total de 42,5M€, destinées à la construction de l’usine de biorecyclage de Longlaville CARBIOS [...]
Ipsen - January 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
06/02/2025
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Janvier 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/02/2025
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Shareholding declaration Valneva SE - January 2025
06/02/2025
VALNEVA Declaration of shares and voting rights January 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]
Déclaration d'actions et de droits de vote de la société Valneva SE - Janvier 2025
06/02/2025
VALNEVA Déclaration d’actions et de droits de vote 31 janvier 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 [...]
University Cancer & Blood Center’s Dr. Ashley Ray receives oncoplastic breast surgery certification
06/02/2025
Acclaimed breast surgeon now performing breast cancer surgery and aesthetic restoration in same procedure ATHENS, Ga., Feb. 06, 2025 (GLOBE NEWSWIRE) -- University Cancer & Blood Center (UCBC), a leading oncology [...]

Pages